Jacqueline Pelphrey, 50, who owned a medical supply shop in Vernon, Connecticut, admitted in federal court on Tuesday that she billed Medicaid and private insurers for custom breast prostheses her clients never ordered, bought or received. She pleaded guilty to one count of health care fraud and acknowledged causing $1,299,633.10 in combined losses to Medicaid and other health insurance plans, the U.S. Attorney’s Office for the District of Connecticut said October 6.
Pelphrey, now of Freedom, Pennsylvania, and formerly of Manchester, Connecticut, owned and operated Women’s Health Resources Inc., which did business as Essentials for the Special Woman. The company sold post-mastectomy items, including custom breast prostheses, and billed health care benefit programs for them. The office says the false claims began no later than August 2018.
The people who stand to be affected by a case like this are patients who had a mastectomy, because their name, plan and diagnosis are the details a phantom claim needs. A patient whose insurer or Medicaid plan paid for a prosthesis the patient never got would first see it as a line on a statement, an explanation of benefits or a Medicaid notice, and the thing to check is whether each item listed matches something that actually arrived.
Pelphrey’s sentencing is set for December 29 in Bridgeport, and the combined loss she admitted is the figure in her plea.
Get the next update the morning it lands →
What Pelphrey admitted in Hartford
On October 6 she waived indictment, which lets a case proceed on a charge filed by prosecutors without a grand jury, and entered her plea in Hartford federal court. The charge, health care fraud, carries a maximum prison term of 10 years. She was released on a $10,000 bond until sentencing, which the release schedules for December 29 in Bridgeport. It does not state a year, and it does not mention restitution.
The $1,299,633.10 is one combined number. It covers Medicaid, private insurers and health care benefit programs whose claims were processed by private insurers, and the release does not split it among them. The scheme, in the office’s words, involved claims for “custom breast prostheses that Pelphrey’s clients did not order, purchase, or receive.”
The coverage the claims leaned on
Breast prostheses are a covered benefit for many people, which is what made them billable. Under the federal Women’s Health and Cancer Rights Act, the Labor Department’s guidance on rights after a mastectomy says group health plans that cover mastectomies must also cover prosthetic devices as part of reconstruction benefits. The law applies whether or not the patient has cancer, and individual policies are generally overseen by state insurance departments. The guidance lists prostheses alongside reconstructive surgery and other mastectomy-related benefits, so a prosthesis is an ordinary covered item for people with a mastectomy.
Medicare has its own rule. Part B covers some external breast prostheses, including a post-surgical bra, after a mastectomy, and after the Part B deductible the patient pays 20% of the Medicare-approved amount, according to Medicare.gov. Medicare was not named in this case, which involved Medicaid and private plans. Because the coverage reaches a post-surgical bra as well as a prosthesis, a Medicare statement listing either one should line up with a fitting, a pickup or a delivery the patient remembers.
The agencies behind the Pelphrey case
The HHS Office of Inspector General and the FBI investigated. Assistant U.S. Attorney David J. Sheldon prosecuted the case, and U.S. Attorney David X. Sullivan announced the plea. The release names Roberto Coviello, the HHS inspector general’s special agent in charge, and P.J. O’Brien, who leads the FBI’s New Haven division.
The announcement also notes that the Justice Department created a National Fraud Enforcement Division on April 7 to go after fraud against the public.
Matching statements against what arrived
The simplest check is a comparison. Medicare.gov advises people to compare the dates and services on their own calendar with the Medicare statements they receive, so each listed service is confirmed as actually received. The same habit applies to a Medicaid or private-plan statement, where a custom item such as a prosthesis can be matched to a fitting appointment, a delivery or a receipt.
Knowing what a plan covers makes the comparison easier. The Labor Department’s guidance says group health plans must give employees a notice at enrollment, and again each year, that describes the mastectomy-related benefits, including any deductibles and coinsurance, so a patient with that notice in hand can tell a normal prosthesis charge from an odd one.
A charge that matches nothing can be reported. Medicare fraud goes to 1-800-MEDICARE (1-800-633-4227), the number on the Medicare reporting page. For Medicaid and other HHS programs, the inspector general takes complaints at 1-800-HHS-TIPS or through its online form. It asks for contact details for the business involved, a short account of what happened and when, and copies of any billing records or documents.
The inspector general’s page adds that anyone seeking a refund or program benefits should pursue other administrative remedies, since not every submission leads to an investigation. A patient who disputes a charge with the plan itself should keep the dates of each call.
More Financial Reading
- 24 Ways to Stretch a $2,087 Social Security Check
- 17 Places to Find Your Share of the $4.25 Billion States Give Back
- 18 Ways Out of 22% Credit Card Interest
This article was produced with AI assistance and reviewed by The Financial Wire’s editorial team.
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
